1. Home
  2. MHN vs ALDX Comparison

MHN vs ALDX Comparison

Compare MHN & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MHN
  • ALDX
  • Stock Information
  • Founded
  • MHN 1997
  • ALDX 2004
  • Country
  • MHN United States
  • ALDX United States
  • Employees
  • MHN N/A
  • ALDX N/A
  • Industry
  • MHN Investment Bankers/Brokers/Service
  • ALDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MHN Finance
  • ALDX Health Care
  • Exchange
  • MHN Nasdaq
  • ALDX Nasdaq
  • Market Cap
  • MHN N/A
  • ALDX 133.7M
  • IPO Year
  • MHN N/A
  • ALDX 2014
  • Fundamental
  • Price
  • MHN $10.02
  • ALDX $2.16
  • Analyst Decision
  • MHN
  • ALDX Strong Buy
  • Analyst Count
  • MHN 0
  • ALDX 2
  • Target Price
  • MHN N/A
  • ALDX $9.50
  • AVG Volume (30 Days)
  • MHN 59.2K
  • ALDX 1.5M
  • Earning Date
  • MHN 01-01-0001
  • ALDX 05-20-2025
  • Dividend Yield
  • MHN 4.17%
  • ALDX N/A
  • EPS Growth
  • MHN N/A
  • ALDX N/A
  • EPS
  • MHN N/A
  • ALDX N/A
  • Revenue
  • MHN N/A
  • ALDX N/A
  • Revenue This Year
  • MHN N/A
  • ALDX N/A
  • Revenue Next Year
  • MHN N/A
  • ALDX N/A
  • P/E Ratio
  • MHN N/A
  • ALDX N/A
  • Revenue Growth
  • MHN N/A
  • ALDX N/A
  • 52 Week Low
  • MHN $8.69
  • ALDX $1.14
  • 52 Week High
  • MHN $10.81
  • ALDX $7.20
  • Technical
  • Relative Strength Index (RSI)
  • MHN 53.46
  • ALDX 34.82
  • Support Level
  • MHN $9.95
  • ALDX $1.90
  • Resistance Level
  • MHN $10.09
  • ALDX $2.89
  • Average True Range (ATR)
  • MHN 0.11
  • ALDX 0.23
  • MACD
  • MHN 0.04
  • ALDX 0.10
  • Stochastic Oscillator
  • MHN 87.27
  • ALDX 26.26

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: